MNDR · Mobile-health Network Solutions Class A Ordinary Shares

This non-binding memorandum signals MNDR’s intent to strengthen its capital base to scale AI-driven healthcare offerings—particularly in sports health and elite athlete care—but imposes no legal obligation on either party to consummate financing. The structure centers on White Group acting as a facilitator, not an investor, with compensation tied solely to successful capital drawdowns. Because the agreement is expressly non-binding and contingent on third-party fund selection, due diligence, and regulatory compliance, investors should view this as exploratory rather than transactional. The focus on sports health represents a strategic vertical expansion beyond MNDR’s existing telehealth platform, aligning with its stated mission to serve both everyday patients and elite athletes. However, no financial terms of any potential investment—such as valuation, governance rights, or control provisions—are disclosed, nor is there any indication of near-term capital availability. The July 2026 target for fund candidate presentation provides a near-term milestone, but execution risk remains high given the absence of committed capital or identified fund partners. For investors, the primary significance lies in management’s prioritization of growth capital for AI-integrated clinical applications—not in imminent balance sheet impact.